Michael Mante

6.7k total citations
69 papers, 4.3k citations indexed

About

Michael Mante is a scholar working on Neurology, Neurology and Physiology. According to data from OpenAlex, Michael Mante has authored 69 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Neurology, 33 papers in Neurology and 27 papers in Physiology. Recurrent topics in Michael Mante's work include Parkinson's Disease Mechanisms and Treatments (33 papers), Alzheimer's disease research and treatments (21 papers) and Neurological Disorders and Treatments (16 papers). Michael Mante is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (33 papers), Alzheimer's disease research and treatments (21 papers) and Neurological Disorders and Treatments (16 papers). Michael Mante collaborates with scholars based in United States, Germany and Austria. Michael Mante's co-authors include Edward Rockenstein, Eliezer Masliah, Anthony Adame, Margaret Mallory, Leslie Crews, Kiren Ubhi, Makoto Hashimoto, Christina Patrick, Brian Spencer and Herbert Moessler and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Neuron.

In The Last Decade

Michael Mante

66 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Mante United States 42 2.0k 1.8k 1.7k 1.3k 1.1k 69 4.3k
Heather L. Melrose United States 29 1.8k 0.9× 1.8k 1.0× 1.2k 0.7× 764 0.6× 1.2k 1.1× 38 3.7k
Reidun Torp Norway 30 902 0.4× 1.4k 0.8× 1.9k 1.1× 745 0.6× 1.8k 1.6× 56 4.0k
Isaac Veinbergs United States 21 1.8k 0.9× 1.6k 0.9× 1.6k 1.0× 696 0.5× 1.1k 0.9× 25 3.7k
Yazi D. Ke Australia 28 781 0.4× 2.6k 1.5× 1.4k 0.8× 850 0.7× 1.6k 1.4× 57 4.2k
Toshio Kawamata Japan 35 1.0k 0.5× 1.6k 0.9× 941 0.6× 1.5k 1.2× 1.5k 1.4× 76 4.2k
Mei Yue United States 21 874 0.4× 2.7k 1.6× 1.5k 0.9× 969 0.8× 1.5k 1.3× 52 4.3k
Byung Kwan Jin South Korea 40 814 0.4× 647 0.4× 1.2k 0.7× 1.4k 1.1× 1.4k 1.2× 91 4.1k
Frank Gillardon Germany 37 1.5k 0.7× 1.0k 0.6× 1.5k 0.9× 752 0.6× 2.2k 1.9× 98 4.6k
Carla L. Busceti Italy 42 1.1k 0.6× 881 0.5× 2.0k 1.2× 615 0.5× 1.7k 1.5× 141 4.6k
Arianna Bellucci Italy 33 1.4k 0.7× 1.0k 0.6× 1.1k 0.6× 783 0.6× 1.0k 0.9× 72 3.2k

Countries citing papers authored by Michael Mante

Since Specialization
Citations

This map shows the geographic impact of Michael Mante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Mante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Mante more than expected).

Fields of papers citing papers by Michael Mante

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Mante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Mante. The network helps show where Michael Mante may publish in the future.

Co-authorship network of co-authors of Michael Mante

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Mante. A scholar is included among the top collaborators of Michael Mante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Mante. Michael Mante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kulbe, Jacqueline R., K.A. Walter, Michael Mante, et al.. (2024). Cannabis Use and Cannabidiol Modulate HIV-Induced Alterations in TREM2 Expression: Implications for Age-Related Neuropathogenesis. Viruses. 16(10). 1509–1509.
2.
Spencer, Brian, Sven Brüschweiler, Marco Sealey‐Cardona, et al.. (2018). Selective targeting of 3 repeat Tau with brain penetrating single chain antibodies for the treatment of neurodegenerative disorders. Acta Neuropathologica. 136(1). 69–87. 23 indexed citations
3.
Kim, Changyoun, Brian Spencer, Edward Rockenstein, et al.. (2018). Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation. Molecular Neurodegeneration. 13(1). 43–43. 121 indexed citations
4.
Rockenstein, Edward, Gary R. Ostroff, Florentina Rus, et al.. (2017). Combined Active Humoral and Cellular Immunization Approaches for the Treatment of Synucleinopathies. Journal of Neuroscience. 38(4). 1000–1014. 41 indexed citations
5.
Price, D. L., Edward Rockenstein, Michael Mante, et al.. (2016). Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson’s Disease/Dementia with Lewy Bodies. Scientific Reports. 6(1). 29523–29523. 42 indexed citations
6.
Kim, Changyoun, Emmanuel A. Ojo-Amaize, Brian Spencer, et al.. (2015). Hypoestoxide reduces neuroinflammation and α-synuclein accumulation in a mouse model of Parkinson’s disease. Journal of Neuroinflammation. 12(1). 236–236. 31 indexed citations
7.
Valera, Elvira, Michael Mante, Scott Anderson, Edward Rockenstein, & Eliezer Masliah. (2015). Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson’s disease. Journal of Neuroinflammation. 12(1). 93–93. 57 indexed citations
8.
Sunico, Carmen R., Tomohiro Nakamura, Edward Rockenstein, et al.. (2013). S-Nitrosylation of parkin as a novel regulator of p53-mediated neuronal cell death in sporadic Parkinson’s disease. Molecular Neurodegeneration. 8(1). 29–29. 66 indexed citations
9.
Winner, Beate, Martin Regensburger, Sebastian R. Schreglmann, et al.. (2012). Role of α-Synuclein in Adult Neurogenesis and Neuronal Maturation in the Dentate Gyrus. Journal of Neuroscience. 32(47). 16906–16916. 104 indexed citations
10.
Masliah, Eliezer, Fang Xie, Edward Rockenstein, et al.. (2010). Genetic deletion of Nogo/Rtn4 ameliorates behavioral and neuropathological outcomes in amyloid precursor protein transgenic mice. Neuroscience. 169(1). 488–494. 41 indexed citations
11.
Ubhi, Kiren, Edward Rockenstein, Michael Mante, et al.. (2010). Neurodegeneration in a Transgenic Mouse Model of Multiple System Atrophy Is Associated with Altered Expression of Oligodendroglial-Derived Neurotrophic Factors. Journal of Neuroscience. 30(18). 6236–6246. 125 indexed citations
12.
Rose, J. Bart, Leslie Crews, Edward Rockenstein, et al.. (2009). Neuropeptide Y Fragments Derived from Neprilysin Processing Are Neuroprotective in a Transgenic Model of Alzheimer's Disease. Journal of Neuroscience. 29(4). 1115–1125. 78 indexed citations
13.
Ubhi, Kiren, Edward Rockenstein, Edith Doppler, et al.. (2009). Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin. Acta Neuropathologica. 117(6). 699–712. 34 indexed citations
14.
Winner, Beate, Edward Rockenstein, D. Chichung Lie, et al.. (2007). Mutant α-synuclein exacerbates age-related decrease of neurogenesis. Neurobiology of Aging. 29(6). 913–925. 107 indexed citations
15.
Rockenstein, Edward, Michael Mante, Anthony Adame, et al.. (2006). Cerebrolysin decreases amyloid‐β production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease. Journal of Neuroscience Research. 83(7). 1252–1261. 72 indexed citations
16.
Rockenstein, Edward, Michael Mante, Michael Alford, et al.. (2005). High β-Secretase Activity Elicits Neurodegeneration in Transgenic Mice Despite Reductions in Amyloid-β Levels. Journal of Biological Chemistry. 280(38). 32957–32967. 85 indexed citations
17.
Shults, Clifford W., Edward Rockenstein, Leslie Crews, et al.. (2005). Neurological and Neurodegenerative Alterations in a Transgenic Mouse Model Expressing Human α-Synuclein under Oligodendrocyte Promoter: Implications for Multiple System Atrophy. Journal of Neuroscience. 25(46). 10689–10699. 189 indexed citations
18.
Rockenstein, Edward, Anthony Adame, Michael Mante, et al.. (2004). Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer?s disease with the neurotrophic compound Cerebrolysin?. Journal of Neural Transmission. 112(2). 269–282. 38 indexed citations
19.
Hashimoto, Makoto, Edward Rockenstein, Michael Mante, Margaret Mallory, & Eliezer Masliah. (2001). β-Synuclein Inhibits α-Synuclein Aggregation. Neuron. 32(2). 213–223. 333 indexed citations
20.
Veinbergs, Isaac, Michael Mante, Margaret Mallory, & Eliezer Masliah. (2000). Neurotrophic effects of Cerebrolysin® in animal models of excitotoxicity. PubMed. 59. 273–280. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026